Neurological involvement in rheumatic disorders and vasculitis in childhood;Afectación neurológica en las enfermedades reumáticas y vasculitis de la infancia

Revista de Neurologia

Volumn 35, Issue 3, 2002, Pages 290-296

  Pineda, M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Childhood; Ischaemic infarcts; Neurological complications; Rheumatic disorders; Thrombosis; Vasculitis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ANAPHYLACTOID PURPURA; ANTIGEN ANTIBODY COMPLEX; ATAXIA; BEHCET DISEASE; BETA HEMOLYTIC STREPTOCOCCUS; BRAIN VASCULITIS; CERVICAL MYELOPATHY; CHILDHOOD DISEASE; CHOREA; CHOREA MINOR; CONFERENCE PAPER; CONVULSION; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NERVE COMPRESSION; NEUROLOGICAL COMPLICATION; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VERTIGO; WEGENER GRANULOMATOSIS;

EID: 0036704999     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3503.2002126     Document Type: Conference Paper

References (48)

1. Foeldevari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 2000; 27: 1069-72.
2. González-Pascual E. Manual Práctico de Reumatología Pediátrica. Barcelona: MRA, SL; 1999.
3. Avraham-Steinberg A, Yitchaz F. Neurological manifestations of systemic diseases in children. International Review of Child Neurology Series. New York: Raven Press; 1993.
4. Kotzin BL. Systemic lupus erythematosus. Cell 1996; 85: 303-6.
5. Lehman TJA, McCurdy DK, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989; 83: 235-9.
6. Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 1981; 24: 1389-95.
7. Linssen WHJP, Fiselier TJW, Cuppen MPMJ, Wevers RA, Gabreels FJ, Rootveel JJ. Acute transverse myelopathy as the initial manifestation of a probable systemic lupus erythematousus in a child. Neuropediatrics 1988; 19: 212-5.
8. Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies: Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987; 44: 876-83.
9. Økseter K, Sirnes K. Chorea and lupus anticoagulant: A case report. Acta Neurol Scand 1988; 78: 206-8.
10. Harbeck RJ, Hoffman AA, Carr RI, Bardana EJ. Complexes of DNA and antibody to DNA were detected in cerebrospinal fluid from patients with SLE. Bull Rheum Dis 1974; 24: 742.
11. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. Am J Roentgenol 1985; 144: 1027-31.
12. McCune WJ, McGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1988; 31: 159-66.
13. Falko JMJC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurological dysfunction in systemic lupus erythematosus. J Pediatrics 1979; 95: 523-6.
14. Singsen BH, Fishman L, Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsivants. Pediatrics 1976; 57: 529-34.
15. Kornreich HK, Koster-King K, Bernstein BH, Singsen BH, Hanson V. Scleroderma in childhood. Arthritis Rheum 1977; 20: 343-50.
16. Farrell DA, Medsger TA Jr. Trigeminal neuropathy in progressive systemic sclerosis. Am J Med 1982; 73: 57-62.
17. Alexander EL, Alexander GE, Provost TT, Stevens MB. Aseptic meningoencephalitis in primary Sjögren's syndrome. Neurology 1983; 33: 593-8.
18. Alexander EL. Sjögren's syndrome: Central nervous system manifestations. Neurology 1981; 31: 1391-6.
19. Hurd EH. Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum 1979; 8: 151-76.
20. Kim RC. Rheumatoid disease with encephalopathy. Ann Neurol 1980; 7: 86-91.
21. O'Connor D, Bernstein B, Hanson V, Kornreich H, King K. Disease of the central nervous system in juvenile rheumatoid arthritis. Arthritis Rheum 1980; 23: 727.
22. Hushby G, Van de Rinjn, Zabriskie JB, Abdin Z, Williams RC. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea acute rheumatic fever. J Exp Med 1976; 144: 1094-110.
23. Zabriskie JB. Rheumatic fever: A streptococcal-induced autoimmune disease? Pediatr Ann 1982; 11: 383-96.
24. Naidu S, Narasimhachari N. Syndeham's chorea: A possible presynaptic dopaminergic dysfunction initially. Ann Neurol 1980; 8: 552-4.
25. Halbreich U, Assael M, Kauly N, Elizar A. Rheumatic brain disease: A disease in its own right. J Nerv Ment Dis 1976; 163: 24-8.
26. Fernández-Álvarez E, Aicardi J. Movement disorders in children. International Review of Child Neurology Series. London: MacKeith Press; 2001.
27. Aron O, Freeman JM, Carter S. The natural history of Syndeham's chorea. Am J Med 1965; 38: 83-95.
28. Roig M, Montserrat L, Gallart L. Carbamazepine: An alternative drug for the treatment of non-hereditary chorea. Pediatrics 1988; 82: 492-5.
29. Jennete JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitis: Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
30. Koutras A. Myositis with Kawasaki's disease. Am J Dis Child 1982; 136: 78-9.
31. Aita JA. Neurologic manifestations of periarteritis nodosa. Neb Med J 1972; 57: 362-6.
32. Reimold EW, Weinberg AG, Fink CW, Battles ND. Polyarteritis in children. Am J Dis Child 1976; 130: 534-41.
33. Walker GL. Neurological features of polyarteritis nodosa. Clin Exp Neurol 1978; 15: 237-47.
34. Orlowski JP, Clough JD, Dyment PG. Wegener's granulomatosis in the pediatric age group. Pediatrics 1978; 61: 83-90.
35. Gibert A, Cambra F, Cusi V, Pineda M, Fernández-Santervás A, Luaces C. Angeítis granulomatosa del sistema nervioso central: A propósito de un caso. An Esp Ped 1996; 45: 441-3.
36. Stern GM, Hoffbrand AV, Urich H. The peripheral nerves and skeletal muscles in Wegener's granulomatosis: A clinicopathological study of four cases. Brain 1965; 88: 151-64.
37. Moorthy AV, Chesney RW, Segar WE, Groshong T. Wegener's granulomatosis in childhood: Prolonged survival following cytotoxic therapy. J Pediatr 1977; 91: 616-8.
38. Belman AL, Leicher CL, Moshe SL, Mezey AP. Neurologic manifestations of Schönlein-Henoch purpura: Report of three cases and review of the literature. Pediatrics 1985; 75: 687-92.
39. Ostergaard JR, Storm K. Neurological manifestations of Schönlein-Henoch purpura. Acta Paedriatr Scand 1991; 80: 339-42.
40. Elinson P, Foster KW, Kaufman DB. Magnetic resonance imaging of central nervous system vasculitis. A case report of Schönlein-Henoch purpura. Acta Paedriatr Scand 1990; 79: 710-3.
41. International study group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
42. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341: 1284-91.
43. Ammann A, Johnson A, Gwendolyn A, Leonards R, Wara D, Cowan M. Behçet's syndrome. J Pediatr 1985; 107: 41-3.
44. Kone PI, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Özdogan H, et al. Clinical features of Behçet's disease in children: An international collaborative study of 86 cases. J Pediatr 1998; 132: 721-5.
45. Gerber-Biondi A, Dormont D, Weschelr B, Marsault C. Long-term MR follow-up of cerebral lesions Behçet's disease. Neuroradiology 1996; 38: 761-8.
46. Pei-Chi-Shek L, Sun Lee Y, Wah Lee B. Thalidomide responsiveness in an infant with Behçet's syndrome. Pediatrics 1999; 103: 1295-7.
47. Serdaroglu P. Behçet's disease and the nervous system. J Neurol 1998; 245: 197-205.
48. Kari JA, Shah V, Dillonn MJ. Behçet's disease in UK children: Clinical features and treatment including thalidomide. Rheumatology 2001; 40: 933-8.